82211-92-5 Usage
General Description
4-(2-chloro-phenyl)-piperidine hydrochloride is a chemical compound that is commonly used in the synthesis of pharmaceutical drugs. It is a piperidine derivative with a chloro-substituted phenyl group, and the hydrochloride salt form is often utilized for its increased solubility and stability. This chemical has been studied for its potential applications in treating various medical conditions, including neurological and psychiatric disorders. Additionally, it may also be used as a building block in the development of new medications and research compounds. The compound's properties and structure make it a valuable tool in the pharmaceutical industry for drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 82211-92-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,2,1 and 1 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 82211-92:
(7*8)+(6*2)+(5*2)+(4*1)+(3*1)+(2*9)+(1*2)=105
105 % 10 = 5
So 82211-92-5 is a valid CAS Registry Number.
InChI:InChI=1/C11H14ClN.ClH/c12-11-4-2-1-3-10(11)9-5-7-13-8-6-9;/h1-4,9,13H,5-8H2;1H
82211-92-5Relevant articles and documents
(4-PHENYL-PIPERIDIN-1-YL)-[5-1H-PYRAZOL-4YL)-THIOPHEN-3-YL]-METHANONE COMPOUNDS AND THEIR USE
-
Page/Page column 75, (2011/04/19)
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain (4-phenyl-piperidin-1-yl)- [5-(1 H-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds that, inter alia, inhibit 11 β-hydroxysteroid dehydrogenase type 1 (11 β-HSD1 ). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit 1 1 β-hydroxysteroid dehydrogenase type 1; to treat disorders that are ameliorated by the inhibition of 11 β-hydroxysteroid dehydrogenase type 1; to treat the metabolic syndrome, which includes disorders such as type 2 diabetes and obesity, and associated disorders including insulin resistance, hypertension, lipid disorders and cardiovascular disorders such as ischaemic (coronary) heart disease; to treat CNS disorders such as mild cognitive impairment and early dementia, including Alzheimer's disease; etc.